News Related to Ion Channels

Related coverage linked through entity extraction aliases.

Galux raises $29 million and partners with OliX on AI-based siRNA delivery

Apr 20, 2026

Galux completed a $29 million Series B financing and entered an MOU with OliX Pharmaceuticals to jointly develop a next-generation AI-based siRNA delivery platform. The funding will support GaluxDesign, R&D expansion and preclinical validation.

FDA Clears First-in-Human Trial of Allogeneic Cell Therapy for Drug-Resistant Epilepsy

Mar 14, 2026

The FDA has authorized the first human trial of an allogeneic stem cell therapy for epilepsy, developed by Shanghai-based Unixell Biotechnology. The therapy uses donor-derived stem cells to produce GABA and suppress seizures in drug-resistant patients.